BULLISHWHALES
BullishWhales · Congress · Trade Detail
NYSE: PFEPfizer Inc
DemocratHouse

Kathy E. Manning sold Pfizer Inc (NYSE: PFE)

Data updated

Analyst view

Kathy E. Manning (D-NC), a U.S. Representative, has disclosed 20 trades in Pfizer Inc (PFE) since 2021, 12 purchases and 8 sales, worth an estimated $209K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Kathy E. Manning sold $1,001 - $15,000 of Pfizer Inc (NYSE: PFE) on August 9, 2024. Since that trade, PFE is down -0.10% against the S&P 500 up +44.49%, an outperformance of -44.59%.

Across these filings, Kathy E. Manning has been a net buyer of PFE (a buy-to-sell ratio of 1.50). Each row in the table below links to that trade and its post-trade performance versus the market.

PFE trades
20
Disclosed Vol
$209K
Buys
12
60%
Sells
8
40%
Buy / Sell
1.50
ratio
First → Last
2021–2024

Kathy E. Manning's PFE trades vs the price

PFE is down -0.10% since Kathy E. Manning sold on August 9, 2024, versus +44.49% for the S&P 500.

Performance since this trade

Price change since trade
-0.10%
S&P 500 change since trade
+44.49%
Outperformance vs S&P 500
-44.59%

All Kathy E. Manning PFE trades

TradedTypeSizeReturn
August 9, 2024SELL$25.37-0.10%
August 9, 2024SELL$25.37-0.10%
December 12, 2023SELL$24.30+4.27%
December 12, 2023SELL$24.30+4.27%
December 12, 2023SELL$24.30+4.27%
December 12, 2023SELL$24.30+4.27%
April 28, 2023BUY$31.92-20.62%
April 28, 2023BUY$31.92-20.62%
October 12, 2022BUY$33.90-25.24%
October 12, 2022BUY$33.90-25.24%
September 12, 2022SELL$38.52-34.21%
September 12, 2022SELL$38.52-34.21%
August 5, 2022BUY$39.74-36.23%
August 5, 2022BUY$39.74-36.23%
July 27, 2022BUY$41.57-39.05%
July 27, 2022BUY$41.57-39.05%
July 15, 2022BUY$41.41-38.81%
July 15, 2022BUY$41.41-38.81%
January 15, 2021BUY$27.82-8.93%
January 15, 2021BUY$27.82-8.93%

Kathy E. Manning's PFE tradesAll congressional filings for Pfizer IncKathy E. Manning's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30